Private equity investing in the healthcare sector in 2022 can be characterized by the lagging effects from COVID-19 and the current effect of financial markets.
Market data, powered by Pitchbook, shows a five-year trend of more deals propelled by underlying demographics, regulatory and market drivers. A potential anomaly was the sharp spike in deal volume in 2021, which is partly attributed to the postponement of certain deals from 2020 due to COVID-19 rather than underlying conditions.
Deal activity within the healthcare sector in 2022 has remained strong and it is likely that underlying market conditions will continue to drive growth with a focus on consolidation and build out of platform deals that traded in 2021 and early 2022, despite some developing headwinds.
Contacts:
Our private equity featured industry insights
No Results Found. Please search again using different keywords and/or filters.